Bridge Therapeutics, Inc.
Pharmaceutical company · Birmingham, Alabama, United States
Bridge Therapeutics, Inc. is a pharmaceutical company headquartered in Birmingham, Alabama, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $321,000 sold in a notice filed in 2023.
Bridge Therapeutics at a glance
What does Bridge Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $321,000 sold (2023).
Frequently asked questions about Bridge Therapeutics
Where is Bridge Therapeutics headquartered?
Bridge Therapeutics, Inc. is headquartered in Birmingham, Alabama, United States.
What does Bridge Therapeutics do?
Bridge Therapeutics, Inc. is a pharmaceutical company.
When was Bridge Therapeutics founded?
The earliest incorporation on record for Bridge Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- ResBiotic Nutrition, Inc.Birmingham, Alabama, United States
- TIXiMED, Inc.Birmingham, Alabama, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences